Komatsu Y, Verweij EJ, Tiblad E, Lopriore E, et al. Design of a Phase 3, Global, Multicenter, Randomized, Placebo-controlled, Double-blind Study of Nipocalimab in Pregnancies At-risk for Severe Hemolytic Disease of the Fetus and Newborn. Am J Perinatol 2024 Aug 28. doi: 10.1055/a-2404-8089.
PMID: 39197469